PAEDIATRIC OBESITY PREVENTION, NUTRITION AND DIETETICS
With
Dr Robyn Littlewood, Chief Executive,
Health and Wellbeing Queensland & Adjunct Professor, University of Queensland, Queensland University of Technology & Griffith University, Australia
RESEARCHER PROFILE
Filmed in Brisbane, Australia | December 2025
Dr Robyn Littlewood is the CEO of Health and Wellbeing Queensland, the state’s prevention agency committed to fostering a healthier and more equitable Queensland.
With over 25 years of experience in clinical care, research and education, Dr Littlewood has made significant contributions to paediatric healthcare. Dr Littlewood is a published author with over 100 publications and has recently released her first book on health and wellbeing for Queensland. She has trained hundreds of students over two decades of frontline service.
Leveraging a systems-based and collaborative approach, Dr Littlewood continues to drive research and data outcomes in the area of health and wellbeing. Dr Littlewood leads a dedicated team focused on making healthy happen for all Queenslanders, with a particular focus on improving health outcomes for our next generation.
Dr Littlewood holds a raft of formal qualifications including a Bachelor of Science and Postgraduate Diploma in Nutrition and Dietetics, a Master of Medical Science, a Masters of Business Administration and a PhD. Dr Littlewood has also completed a number of postgraduate qualifications in executive leadership and is a member of the Australian Institute of Company Directors. Dr Littlewood holds Adjunct Professor appointments from UQ, QUT and Griffith universities, has been awarded Fellow of Dietitians Australia, the Barbara Chester Award and QUT Health Alumni of the year in recognition of her outstanding contribution to the dietetics profession.
Source: Supplied
https://orcid.org/0000-0002-9955-3662
-
Discovery of RANK Ligand’s role in bone metabolism and the immune system to treat osteoporosis
Emeritus Professor Jack Martin’s research began a discovery cascade that led to the identification of a new protein and the development of a novel and effective drug therapy that is now used worldwide to treat osteoporosis, cancer and other diseases.
-
Relationship between mental illness and mental wellbeing
Since 2015, Dr Matthew Iasiello has been working on the development and dissemination of mental wellbeing interventions across the Australian community at the South Australian Health and Medical Research Institute (SAHMRI). His PhD research was designed specifically to strengthen the translational work conducted by SAHMRI, and to solve problems that represented gaps in the literature that were arising when delivering mental wellbeing interventions into the community. The impact and relevance of Dr Iasiello’s work has been demonstrated with invited presentations at international academic conferences, and multiple media stories with significant online engagements.
-
Nanoparticles & microparticles to combat antimicrobial resistance
Dr Anjana Jayasree is an emerging research leader in biomaterials, tissue engineering and nanotechnology, recognised internationally for her innovative work on antimicrobial nanoparticles and regenerative therapies. A Postdoctoral Research Fellow at The University of Queensland, she operates at the intersection of materials science, drug delivery and cellular biology, developing advanced metallic-based nanotechnologies to improve both human and animal health outcomes. Her expertise spans nanoparticle synthesis, cell–material interactions, and the design of sophisticated in vitro models to investigate soft-tissue integration, osseointegration, angiogenesis and biofilm formation.
